Whitfield Dianne C.

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
17 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Whitfield Dianne C.'s trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-19
S Sale
57,612 +37.4%
479.95
US$1,575,893 		57,612 +37.4% 479.95 US$1,575,893
2026-03-19 2026-03-19
PrS Proposed sale
54,572
222.15
US$86,946 		54,572 222.15 US$86,946
2026-03-19 2026-03-18
S Sale
5,928 +28.3%
184.55
US$2,612,033 		5,928 +28.3% 184.55 US$2,612,033
2026-03-18 2026-03-18
PrS Proposed sale
4,071
68.71
US$279,718 		4,071 68.71 US$279,718
2026-03-19 2026-03-17
S Sale
4,029 -8.5%
69.42
US$279,693 		4,029 -8.5% 69.42 US$279,693
2026-03-17 2026-03-17
PrS Proposed sale
4,029
69.41
US$279,672 		4,029 69.41 US$279,672
2026-01-06 2026-01-02
PlS Planned sale
893 -3.7%
82.93
US$74,056 		893 -3.7% 82.93 US$74,056
2026-01-06 2026-01-02
PlS Planned sale
835 -3.3%
81.90
US$68,386 		835 -3.3% 81.90 US$68,386
2026-01-06 2026-01-02
PlS Planned sale
8,122 -24.4%
80.71
US$655,527 		8,122 -24.4% 80.71 US$655,527
2026-01-06 2026-01-02
PlS Planned sale
5,715 -14.7%
80.09
US$457,714 		5,715 -14.7% 80.09 US$457,714
2026-01-02 2026-01-02
PrS Proposed sale
15,565
81.38
US$1,266,680 		15,565 81.38 US$1,266,680
2025-12-18 2025-12-16
PlS Planned sale
7,397 -16.0%
80.10
US$592,500 		7,397 -16.0% 80.10 US$592,500
2025-12-16 2025-12-16
PrS Proposed sale
7,397
80.10
US$592,500 		7,397 80.10 US$592,500
2025-03-20 2025-03-20
PrS Proposed sale
2,137
50.11
US$107,093 		2,137 50.11 US$107,093
2025-03-20 2025-03-20
S Sale
2,137 -4.4%
50.11
US$107,085 		2,137 -4.4% 50.11 US$107,085
2025-03-20 2025-03-19
S Sale
2,259 -4.5%
47.40
US$107,077 		2,259 -4.5% 47.40 US$107,077
2025-03-19 2025-03-19
PrS Proposed sale
2,259
47.40
US$107,075 		2,259 47.40 US$107,075
2025-03-20 2025-03-18
S Sale
2,315 -4.4%
46.29
US$107,161 		2,315 -4.4% 46.29 US$107,161
2025-03-18 2025-03-18
PrS Proposed sale
2,315
46.28
US$107,149 		2,315 46.28 US$107,149
2024-03-19 2024-03-18
S Sale
4,314 -11.2%
30.60
US$132,008 		4,314 -11.2% 30.60 US$132,008
2024-03-18 2024-03-18
PrS Proposed sale
4,314
30.60
US$131,998 		4,314 30.60 US$131,998
2023-12-01 2023-11-30
S Sale
8,355 -23.8%
16.31
US$136,270 		8,355 -23.8% 16.31 US$136,270
2023-11-30 2023-11-30
PrS Proposed sale
8,355
16.31
US$136,255 		8,355 16.31 US$136,255
2023-03-23 2023-03-23
S Sale
345 -3.0%
12.15
US$4,192 		345 -3.0% 12.15 US$4,192
2023-03-23 2023-03-22
S Sale
333 -2.8%
12.64
US$4,209 		333 -2.8% 12.64 US$4,209
2023-03-23 2023-03-21
S Sale
326 -2.7%
12.89
US$4,202 		326 -2.7% 12.89 US$4,202
2023-03-21 2023-03-20
S Sale
333 -2.7%
12.61
US$4,199 		333 -2.7% 12.61 US$4,199
2023-03-21 2023-03-17
S Sale
316 -2.5%
13.28
US$4,196 		316 -2.5% 13.28 US$4,196
2023-03-17 2023-03-16
S Sale
313 -2.4%
13.43
US$4,204 		313 -2.4% 13.43 US$4,204
2023-03-16 2023-03-16
PrS Proposed sale
2,015
13.66
US$27,525 		2,015 13.66 US$27,525
2022-12-06 2022-12-02
S Sale
1,154 -11.7%
16.90
US$19,503 		1,154 -11.7% 16.90 US$19,503
2022-12-01 2022-12-01
S Sale
1,165 -10.6%
16.75
US$19,514 		1,165 -10.6% 16.75 US$19,514
2022-12-01 2022-11-30
S Sale
1,182 -9.7%
16.50
US$19,503 		1,182 -9.7% 16.50 US$19,503